Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 172

The DOI matches its Crossref record.

Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM

Open access
Suchorska, Bogdana, Jansen, Nathalie L., Linn, Jennifer, Kretzschmar, Hans, Janssen, Hendrik, Eigenbrod, Sabina, Simon, Matthias, Pöpperl, Gabriele, Kreth, Friedrich W., la Fougere, Christian, Weller, Michael, Tonn, Joerg C., For the German Glioma Network, Suchorska, Bogdana, Jansen, Nathalie Lisa, Linn, Jennifer, Kretzschmar, Hans, Janssen, Hendrik, Eigenbrod, Sabina, Simon, Matthias, Pöpperl, Gabriele, Kreth, Friedrich Wilhelm, La Fougere, Christian, Weller, Michael, Tonn, Joerg Christian, Schnell, Oliver, Geisler, Julia, Henschel, Bettina · 2015 · Neurology

Abstract

OBJECTIVE: The aim of this prospective longitudinal study was to identify static and dynamic O-(2-[(18)F]fluoroethyl)-L-tyrosine PET ((18)FET-PET)-derived imaging biomarkers in patients with glioblastoma (GBM). METHODS: Seventy-nine patients with newly diagnosed GBM were included; 42 patients underwent stereotactic biopsy (unresectable tumors) and 37 patients microsurgical tumor resection. All patients were scheduled to receive radiotherapy plus concomitant and adjuvant temozolomide (RCx/TMZ). (18)FET-PET evaluation using static and dynamic analysis was done before biopsy/resection, after resection, 4 to 6 weeks following RCx, and after 3 cycles of TMZ. Endpoints were survival and progression-free-survival. Prognostic factors were obtained from proportional hazards models. RESULTS: Biological tumor volume before RCx (BTV(preRCx)) was the most important (18)FET-PET-derived imaging biomarker and was independent of MGMT promoter methylation and clinical prognostic factors: patients with smaller BTV(preRCx) had significantly longer progression-free and overall survival (OS). (18)FET time-activity curves (TACs) before treatment and their changes after RCx were also related to outcome; patients with initially increasing TACs experienced longer OS. CONCLUSION: BTV(preRCx) and TAC represent important (18)FET-PET-derived imaging biomarkers in GBM. Increasing TACs are associated with prolonged OS. The BTV(preRCx) is a strong prognostic factor for progression-free survival and OS independent of the mode of surgery. Our data furthermore suggest that patients harboring resectable GBM might benefit from maximal PET-guided tumor resection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000001262

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 172

Metadata

Authors
Suchorska, B., Jansen, N. L., Linn, J., Kretzschmar, H., Janssen, H., Eigenbrod, S., Simon, M., Pöpperl, G., Kreth, F. W., la Fougere, C., Weller, M., Tonn, J. C., For the German Glioma Network, Suchorska, B., Jansen, N. L., Linn, J., Kretzschmar, H., Janssen, H., Eigenbrod, S., Simon, M., Pöpperl, G., Kreth, F. W., La Fougere, C., Weller, M., Tonn, J. C., Schnell, O., Geisler, J., & Henschel, B.
Venue
Neurology
Published
2015-02-17
Volume
84
Issue
7
Pages
710-719
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2109896919
Cited by
172
References
0
FWCI
9.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM. https://app.cochat.ai/papers/10.1212/wnl.0000000000001262
The paper
Suchorska, B., Jansen, N. L., Linn, J., Kretzschmar, H., Janssen, H., Eigenbrod, S., Simon, M., Pöpperl, G., Kreth, F. W., la Fougere, C., Weller, M., Tonn, J. C., For the German Glioma Network, Suchorska, B., Jansen, N. L., Linn, J., Kretzschmar, H., Janssen, H., Eigenbrod, S., . . . Henschel, B. (2015). Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM. Neurology. https://doi.org/10.1212/wnl.0000000000001262

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.